Company Filing History:
Years Active: 2010-2018
Title: Susan Kane: Innovator in Cancer Detection and Insulin Regulation
Introduction
Susan Kane is a notable inventor based in Beverly, MA (US), recognized for her contributions to the fields of cancer detection and insulin regulation. With a total of two patents to her name, she has made significant strides in medical research and innovation.
Latest Patents
Her latest patents include "Compositions and methods for detecting EGFR in cancer," which discloses binding agents to the E746-A750 deletion and the L858R point mutations in the epidermal growth factor receptor (EGFR) molecule. This invention provides methods for the diagnosis and treatment of cancer. Another significant patent is "Method for identifying agents which modulate GTPase activity involved in insulin-stimulated GLUT4 translocation." This invention outlines a method for identifying agents that modulate the GTPase activity of AS160, monitoring the hydrolysis of GTP to GDP in the presence of test agents.
Career Highlights
Throughout her career, Susan Kane has worked with esteemed institutions such as Dartmouth College and Cell Signaling Technology, Inc. Her work has contributed to advancements in understanding cancer biology and metabolic processes.
Collaborations
She has collaborated with notable colleagues, including Gustav E. Lienhard and Cristinel P. Miinea, further enhancing her research and innovation efforts.
Conclusion
Susan Kane's innovative work in cancer detection and insulin regulation highlights her significant impact on medical research. Her patents reflect her dedication to advancing healthcare solutions and improving patient outcomes.